Orgenesis (ORGS)
(Delayed Data from NSDQ)
$0.53 USD
-0.02 (-2.95%)
Updated May 3, 2024 04:00 PM ET
After-Market: $0.54 +0.01 (2.47%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Orgenesis Inc. [ORGS]
Reports for Purchase
Showing records 1 - 14 ( 14 total )
Company: Orgenesis Inc.
Industry: Medical - Biomedical and Genetics
We are terminating coverage of Orgenesis Inc. due to reallocation of resources.
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: Orgenesis Inc.
Industry: Medical - Biomedical and Genetics
First Meaningful Revenues through POCare Platform Contribute to Record Results
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: Orgenesis Inc.
Industry: Medical - Biomedical and Genetics
Company: Orgenesis Inc.
Industry: Medical - Biomedical and Genetics
Company: Orgenesis Inc.
Industry: Medical - Biomedical and Genetics
New Facility Set to Dramatically Expand Production Capability
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: Orgenesis Inc.
Industry: Medical - Biomedical and Genetics
Record Results While Targeting Enormous and Rapidly Expanding Cell Therapy Manufacturing Market with Innovative Point of Care Solution
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: Orgenesis Inc.
Industry: Medical - Biomedical and Genetics
We are initiating coverage on Orgenesis with a Buy rating and a $10.00 price target
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WERTHER C
Company: Orgenesis Inc.
Industry: Unclassified
Strong Execution Continues with Unprecedented Industry Growth
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: Orgenesis Inc.
Industry: Medical - Biomedical and Genetics
Strong Execution Continues with Unprecedented Industry Growth
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: Orgenesis Inc.
Industry: Unclassified
Company: Orgenesis Inc.
Industry: Unclassified
Company: Orgenesis Inc.
Industry: Unclassified
SMALL-CAP SQUAWK
Provider: JGR Capital Partners
Company: Orgenesis Inc.
Industry: Unclassified
KITE Deal Bodes Well For M-A Within Cellular Therapy
Provider: DIAMOND EQUITY RESEARCH LLC
Company: Orgenesis Inc.
Industry: Medical - Biomedical and Genetics
Initiation Unique Global Manufacturing Platform Poised To Generate Expanding Cash Flow.
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
|